Safety and efficacy of single intravitreal injection of ranibizumab in macular edema secondary to recent nonischemic retinal vein occlusion
Objectives This study was designed to evaluate the safety and efficacy of a single large dose (0.7 mg) of ranibizumab for treatment of macular edema secondary to nonischemic central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO). Setting and design A prospective interventional...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Delta Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.djo.eg.net/article.asp?issn=1110-9173;year=2017;volume=18;issue=1;spage=44;epage=47;aulast=Ibrahim |